The practical differences often come down to individual tolerance, availability, insurance coverage, and the specific indication (diabetes versus obesity)
Through this detailed examination, we aim to shed light on the complexities of treating conditions like diabetes and obesity within the context of hormonal balance and therapy, providing insights into potential benefits, risks, and considerations for personalized treatment approaches
However, research here is still ongoing
Oral GLP-1 options and how they differ from injections Oral GLP-1 options are an active area of research
Gastrointestinal side effects like nausea can reduce fluid intake, leading to dehydration and orthostatic hypotension
Last reviewed: May 19, 2026 Last updated: May 19, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations